JP2012501986A5 - - Google Patents

Download PDF

Info

Publication number
JP2012501986A5
JP2012501986A5 JP2011525465A JP2011525465A JP2012501986A5 JP 2012501986 A5 JP2012501986 A5 JP 2012501986A5 JP 2011525465 A JP2011525465 A JP 2011525465A JP 2011525465 A JP2011525465 A JP 2011525465A JP 2012501986 A5 JP2012501986 A5 JP 2012501986A5
Authority
JP
Japan
Prior art keywords
pain
medicament
preparation
treatment
combination according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011525465A
Other languages
English (en)
Other versions
JP2012501986A (ja
JP5731387B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/006424 external-priority patent/WO2010025931A2/en
Publication of JP2012501986A publication Critical patent/JP2012501986A/ja
Publication of JP2012501986A5 publication Critical patent/JP2012501986A5/ja
Application granted granted Critical
Publication of JP5731387B2 publication Critical patent/JP5731387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

別の態様では、本発明は、以下に限定されるものではないが、好ましくは炎症性痛、神経因性痛、急性痛、慢性痛、内臓痛、片頭痛および癌の痛みなどの痛みの治療用薬剤を調製するための、本明細書に記載するような発明性のある配合剤の使用に関する。

Claims (1)

  1. 痛みの治療用薬剤の調製のための、請求項１〜８のいずれか一項に記載の配合剤の使用。
JP2011525465A 2008-09-05 2009-09-04 医薬配合剤 Active JP5731387B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08015625.0 2008-09-05
EP08015625 2008-09-05
PCT/EP2009/006424 WO2010025931A2 (en) 2008-09-05 2009-09-04 Pharmaceutical combination

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014251851A Division JP2015096530A (ja) 2008-09-05 2014-12-12 医薬配合剤

Publications (3)

Publication Number Publication Date
JP2012501986A JP2012501986A (ja) 2012-01-26
JP2012501986A5 true JP2012501986A5 (ja) 2014-07-24
JP5731387B2 JP5731387B2 (ja) 2015-06-10

Family

ID=40345058

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011525465A Active JP5731387B2 (ja) 2008-09-05 2009-09-04 医薬配合剤
JP2014251851A Pending JP2015096530A (ja) 2008-09-05 2014-12-12 医薬配合剤
JP2016240032A Pending JP2017071636A (ja) 2008-09-05 2016-12-12 医薬配合剤
JP2019070282A Pending JP2019131578A (ja) 2008-09-05 2019-04-02 医薬配合剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2014251851A Pending JP2015096530A (ja) 2008-09-05 2014-12-12 医薬配合剤
JP2016240032A Pending JP2017071636A (ja) 2008-09-05 2016-12-12 医薬配合剤
JP2019070282A Pending JP2019131578A (ja) 2008-09-05 2019-04-02 医薬配合剤

Country Status (29)

Country Link
US (1) US20100063148A1 (ja)
EP (2) EP2331210B1 (ja)
JP (4) JP5731387B2 (ja)
KR (3) KR101641519B1 (ja)
CN (2) CN102159284B (ja)
AR (2) AR073361A1 (ja)
AU (3) AU2009289776A1 (ja)
BR (1) BRPI0920521A2 (ja)
CA (1) CA2735857C (ja)
CL (1) CL2011000317A1 (ja)
CO (1) CO6382142A2 (ja)
CY (2) CY1115751T1 (ja)
DK (2) DK2735338T3 (ja)
EC (1) ECSP11010869A (ja)
ES (2) ES2513394T3 (ja)
HK (2) HK1159011A1 (ja)
HR (2) HRP20140663T1 (ja)
HU (1) HUE043278T2 (ja)
IL (3) IL211135A (ja)
LT (1) LT2735338T (ja)
MX (1) MX2011002339A (ja)
PE (5) PE20142372A1 (ja)
PL (2) PL2331210T3 (ja)
PT (2) PT2735338T (ja)
RU (2) RU2674150C1 (ja)
SI (2) SI2331210T1 (ja)
TR (1) TR201904388T4 (ja)
WO (1) WO2010025931A2 (ja)
ZA (1) ZA201101449B (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
EA027836B1 (ru) * 2006-06-15 2017-09-29 ЮСиБи ФАРМА ГМБХ Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение
KR101641519B1 (ko) * 2008-09-05 2016-07-21 그뤼넨탈 게엠베하 3-（3-디메틸아미노-1-에틸-2-메틸-프로필）-페놀과 항간질제의 약제학적 병용물
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
FR2943246B1 (fr) * 2009-03-19 2011-07-29 Biocodex Compose pour son utilisation dans le traitement des neuropathies peripheriques
US8846765B2 (en) 2010-06-15 2014-09-30 Gruenenthal Gmbh Pharmaceutical combination
AU2011276170B2 (en) 2010-07-06 2016-03-10 Grunenthal Gmbh Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid
EP2599487B1 (en) 2010-07-30 2015-04-01 Toray Industries, Inc. Therapeutic agent or prophylactic agent for neuropathic pain
CN107088226A (zh) * 2011-03-04 2017-08-25 格吕伦塔尔有限公司 他喷他多的胃肠外给药
ES2712072T3 (es) * 2011-07-20 2019-05-09 Torrent Pharmaceuticals Ltd Composición farmacéutica de tapentadol
NO2736501T3 (ja) * 2011-07-29 2018-05-19
US8912226B2 (en) * 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9855286B2 (en) * 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9345689B2 (en) * 2012-05-18 2016-05-24 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9308196B2 (en) * 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9320725B2 (en) * 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
BR112015009839A2 (pt) * 2012-11-01 2017-07-11 Torrent Pharmaceuticals Ltd composição farmacêutica de tapentadol para administração parenteral
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN103655523A (zh) * 2013-12-24 2014-03-26 南京艾德凯腾生物医药有限责任公司 他喷他多组合物
RU2731179C2 (ru) 2015-12-22 2020-08-31 Зодженикс Интернэшнл Лимитед Фенфлураминовые композиции и способы их получения
EP3393470B1 (en) 2015-12-22 2021-01-20 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
JP2019526544A (ja) 2016-08-24 2019-09-19 ゾゲニクス インターナショナル リミテッド ５−ｈｔ２ｂアゴニストの形成を阻害するための製剤およびその使用方法
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
KR20190081385A (ko) 2017-12-29 2019-07-09 강원대학교산학협력단 옥스카바제핀을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물
US11571397B2 (en) 2018-05-11 2023-02-07 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US5472711A (en) 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5330761A (en) 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5455046A (en) 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399362A (en) 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
WO2001013904A2 (en) * 1999-08-20 2001-03-01 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and an anticonvulsant drug
WO2003061656A1 (en) * 2002-01-16 2003-07-31 Endo Pharmaceuticals Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
CA2476438A1 (en) * 2002-02-22 2003-08-28 Warner-Lambert Company Llc Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
WO2007005716A2 (en) * 2005-06-30 2007-01-11 Cinergen, Llc Methods of treatment and compositions for use thereof
WO2007087452A2 (en) * 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Abuse resistant and extended release formulations and method of use thereof
EP2012763B1 (en) * 2006-04-28 2011-03-23 Grünenthal GmbH Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid
WO2008027442A2 (en) * 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
MX2010005680A (es) * 2007-11-23 2010-12-21 Protect Pharmaceutical Corp Composiciones de tapentadol.
CA2706575C (en) * 2008-01-25 2015-07-14 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
KR101641519B1 (ko) * 2008-09-05 2016-07-21 그뤼넨탈 게엠베하 3-（3-디메틸아미노-1-에틸-2-메틸-프로필）-페놀과 항간질제의 약제학적 병용물

Similar Documents

Publication Publication Date Title
JP2012501986A5 (ja)
IL255752B (en) Compounds, pharmaceutical preparations containing the same uses for the treatment of cardiovascular disease, inflammatory diseases and cancer
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
MX2010003299A (es) Oligonucleotidos muy cortos (micromirs).
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
JP2014530840A5 (ja)
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
IL216599A (en) 4,1-Bi-Conjugated Phthalazine History, Pharmaceuticals Containing Them and Their Use in Cancer Treatment
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
JP2013231052A5 (ja)
JP2009532412A5 (ja)
TH92434B (th) เก้าอี้
TH99550B (th) เตียงนอนแบบปรับระดับพนักพิง
TH99551B (th) เตียงนอนแบบปรับระดับพนักพิง
TH122852B (th) อ่างอาบน้ำ
UA102529C2 (en) Microribonucleic acids
TH92418B (th) เตียงนอนแบบปรับระดับพนักพิง
TH93116B (th) เก้าอี้
TH108693B (th) เตียง
TH108688B (th) เตียง
TH102233B (th) เตียงนอนแบบปรับระดับพนักพิง
TH92194B (th) เตียงแบบปรับได้
TH105243B (th) เตียงนอนแบบปรับระดับพนักพิง
TH105244B (th) เตียงนอนแบบปรับระดับพนักพิง
TH123802B (th) เตียง